| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christina A Brezing, Mohammad Sibai, C Jean Choi, Souparno Mitra, John J Mariani, Nasir Naqvi, Amy L Mahony, Daniel Brooks, Martina Pavlicova, Frances R Levi. Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder. Journal of substance use. vol 29. issue 4. 2024-07-18. PMID:39021751. |
cannabis use disorder (cud) has no fda approved treatment. |
2024-07-18 |
2024-07-20 |
human |
| Nikola Zaharakis, J Douglas Coatsworth, Nathaniel R Riggs, Aubrie Radford, Stephanie Rayburn, Jeremy Mennis, Michael A Russell, Aaron Brown, Michael J Maso. Treating young adult cannabis use disorder with text message-delivered peer network counseling. Contemporary clinical trials. 2024-07-17. PMID:39019156. |
approximately 16.5% of u.s. young adults have a cannabis use disorder (cud) and are at risk for negative outcomes. |
2024-07-17 |
2024-07-20 |
human |
| Alisa Stampf, Larissa Schwarzkopf, Albert Batalla, Daniel Feingold, Benedikt Fischer, Eva Hoc. Cannabis-related treatment demand at the eve of German cannabis legalization - a 20-years trend analysis. European archives of psychiatry and clinical neuroscience. 2024-07-01. PMID:38951248. |
treatment demand related to cannabis use disorder (cud) for the period 2001 to 2021 was investigated using data from the nation-wide standardized german addiction care statistical service. |
2024-07-01 |
2024-07-04 |
Not clear |
| Rupak Desai, Nitin Ghadge, Sai Gautham Kanagala, Nishanth Katukuri, Alpha James, Avinash Kadiyala, Sai Diksha Vutukuru, Meghana Kotharu, Tajdin Borzoo, Akhila Nalla, Ankit Vyas, Shivani Priyadarshni, Mostafa Shalaby, Wissam Khalif. Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in-Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis. Journal of the American Heart Association. 2024-06-27. PMID:38934855. |
with the increase in popularity of cannabis and its use and the lack of large-scale data on cannabis use and venous thromboembolism and pulmonary embolism (pe), we used a nationally representative cohort of young adults (aged 18-44 years) to compare the odds of admissions and in-hospital mortality of pe with and without cannabis use disorder (cud). |
2024-06-27 |
2024-06-29 |
Not clear |
| Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xi. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. Schizophrenia bulletin. 2024-06-20. PMID:38900958. |
up to 43% of people with schizophrenia have a lifetime cannabis use disorder (cud). |
2024-06-20 |
2024-06-23 |
Not clear |
| Isaac C Rhew, Sabrina Oesterle, Margaret R Kuklinski, Katarina Guttmannova, Jennifer M Cadiga. The longitudinal association of cumulative depression with cannabis use disorder among young adults. Journal of studies on alcohol and drugs. 2024-06-20. PMID:38900055. |
this study examined whether the cumulative experience of elevated depressive symptoms from age 19 to 23 was associated with cannabis use disorder (cud) at age 26, and whether the association varied by perceived ease of access to cannabis and perceived risk for harms from cannabis use. |
2024-06-20 |
2024-06-22 |
Not clear |
| Alexis Blessing, Patricia D Russell, Madison S Stout, Juan Barerra-Barker, Sandra B Morissett. The Influence of Anxiety and Avoidant Coping on Probable Cannabis Use Disorder. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883279. |
individuals with anxiety frequently use cannabis to cope and are at greater risk for developing probable cannabis use disorder (cud). |
2024-06-17 |
2024-06-19 |
Not clear |
| Kirstyn N Smith-LeCavalier, Paige M Morris, Mary E Larimer, Julia D Buckner, Katherine Walukevich-Diens. General and Domain-Specific Perceived Risk Demonstrate Unique Associations with Cannabis Use, Negative Outcomes, and Motivation to Change among Undergraduate Students. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883284. |
thus, among 130 undergraduates who reported past-month cannabis use, the present study conducted secondary analyses to test whether, for both perceived risk to others and perceived personal risk: (1) general perceived risk was associated with cannabis-related outcomes (i.e., use, negative consequences, cannabis use disorder (cud) symptoms, motivation to change), (2) seven specific domains of perceived risk were related to cannabis outcomes, and (3) domain-specific perceived risk was related to cannabis use frequency. |
2024-06-17 |
2024-06-19 |
human |
| Kirstyn N Smith-LeCavalier, Paige M Morris, Mary E Larimer, Julia D Buckner, Katherine Walukevich-Diens. General and Domain-Specific Perceived Risk Demonstrate Unique Associations with Cannabis Use, Negative Outcomes, and Motivation to Change among Undergraduate Students. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883284. |
general perceived risk to others was negatively associated with cannabis use frequency whereas general perceived personal risk was positively associated with cannabis-related negative consequences, cud symptoms, and importance and readiness to change. |
2024-06-17 |
2024-06-19 |
human |
| Renee Martin-Willett, Joshua S Elmore, Paige X Phillips, L Cinnamon Bidwel. Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions. Psychiatry and clinical psychopharmacology. vol 34. issue 1. 2024-06-17. PMID:38883882. |
based on the complication of these tools, 5 areas of potential development are highlighted to guide future research, including (i) sensitivity to the mode of cannabis administration as well as sensitivity to (ii) potency of cannabis products alongside frequency and quantity, (iii) unit equivalence, (iv) aligning clinical measures consistently with cannabis use disorder (cud) diagnostic criteria, and (v) creating measures specific to medical users, their motives for use, and their perceptions of therapeutic benefits or side effects. |
2024-06-17 |
2024-06-19 |
Not clear |
| Renee Martin-Willett, Joshua S Elmore, Paige X Phillips, L Cinnamon Bidwel. Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions. Psychiatry and clinical psychopharmacology. vol 34. issue 1. 2024-06-17. PMID:38883882. |
clinicians and researchers can pragmatically benefit from this summary of validated measures of cannabis use, and future work could improve the study of and clinical care for cannabis use and cud by pursuing one or more key areas of development described here. |
2024-06-17 |
2024-06-19 |
Not clear |
| Mark K Britton, Jason DeFelice, Eric C Porges, Ronald Cohen, Yancheng Li, Yan Wang, Gladys E Ibañez, Charurut Somboonwit, Robert L Coo. Association between cannabis use disorder and greater apathy in adults with HIV. Drug and alcohol dependence. vol 261. 2024-06-13. PMID:38870567. |
cannabis use and cannabis use disorder (cud) are also disproportionately prevalent among pwh. |
2024-06-13 |
2024-06-16 |
Not clear |
| Mark K Britton, Jason DeFelice, Eric C Porges, Ronald Cohen, Yancheng Li, Yan Wang, Gladys E Ibañez, Charurut Somboonwit, Robert L Coo. Association between cannabis use disorder and greater apathy in adults with HIV. Drug and alcohol dependence. vol 261. 2024-06-13. PMID:38870567. |
cud and younger onset of cannabis use may be linked to apathy in the general population; however, patterns of use most strongly associated with apathy have not been firmly established, and it is unclear whether cannabis use is linked to apathy in pwh. |
2024-06-13 |
2024-06-16 |
Not clear |
| Maha N Mian, Varada Sarovar, Tory Levine, Alexandra Lea, Amy Leibowitz, Mitchell Luu, Jason Flamm, C B Hare, Michael Horberg, Kelly Young-Wolff, Kristina Phillips, Michael Silverberg, Derek Satr. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. Research square. 2024-06-10. PMID:38853848. |
we examined factors associated with indicators risk for cannabis use disorder (cud) among pwh who used cannabis. |
2024-06-10 |
2024-06-14 |
human |
| Maha N Mian, Varada Sarovar, Tory Levine, Alexandra Lea, Amy Leibowitz, Mitchell Luu, Jason Flamm, C B Hare, Michael Horberg, Kelly Young-Wolff, Kristina Phillips, Michael Silverberg, Derek Satr. Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care. Research square. 2024-06-10. PMID:38853848. |
primary outcome was taps cannabis score (range 1-3), categorized as any use (1) and higher risk for cud (≥ 2). |
2024-06-10 |
2024-06-14 |
human |
| Youqian Zhang, Yue Su, Zitian Tang, Lin L. The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis. International journal of impotence research. 2024-06-04. PMID:38834872. |
this study utilized genome-wide association study (gwas) data to investigate the causal relationships between cannabis use disorder (cud), lifetime cannabis use (lcu), and ed, as well as levels of sex hormones including estradiol (e2), bioavailable testosterone (bt), follicle-stimulating hormone (fsh), and luteinizing hormone (lh) through mendelian randomization (mr) analysis. |
2024-06-04 |
2024-06-07 |
Not clear |
| Ardavan Mohammad Aghaei, Lia Urban Spillane, Brian Pittman, L Taylor Flynn, Joao P De Aquino, Anahita Bassir Nia, Mohini Ranganatha. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study. Psychopharmacology. 2024-06-04. PMID:38832949. |
recent reports have shown increased cannabis use among women, leading to growing concerns about cannabis use disorder (cud). |
2024-06-04 |
2024-06-06 |
human |
| Marco Bortolato, Giulia Braccagni, Casey A Pederson, Gabriele Floris, Paula J Fit. "Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression. Aggression and violent behavior. vol 78. 2024-06-03. PMID:38828012. |
this trend has shed light on a significant link between cannabis use disorder (cud) and pathological reactive aggression, a condition involving disproportionate aggressive and violent reactions to minor provocations. |
2024-06-03 |
2024-06-05 |
human |
| Abay Woday Tadesse, Getinet Ayano, Berihun Assefa Dachew, Kim Betts, Rosa Alat. Exposure to maternal cannabis use disorder and risk of autism spectrum disorder in offspring: A data linkage cohort study. Psychiatry research. vol 337. 2024-05-24. PMID:38788554. |
this study aimed to investigate the association between pre-pregnancy, prenatal and perinatal exposures to cannabis use disorder (cud) and the risk of autism spectrum disoder (asd) in offspring. |
2024-05-24 |
2024-05-27 |
Not clear |
| Cheng Ding, Dongdong Xu, Tao Chen. Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies. The Journal of the American Academy of Orthopaedic Surgeons. 2024-05-17. PMID:38759231. |
with the legalization of marijuana in the united states, the number of patients with cannabis use disorder (cud) in the joint arthroplasty population has increased markedly. |
2024-05-17 |
2024-05-27 |
Not clear |